Zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: health-related quality of life in a subgroup of Chinese patients in the ALPINE trial

Authors

Institutions

Publication Details

Journal
Current Medical Research and Opinion
Published
2026-01-02
DOI
https://doi.org/10.1080/03007995.2026.2623629
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: health-related quality of life in a subgroup of Chinese patients in the ALPINE trial

Constantine S. Tam, Tommi Salmi, L. Qiu, Rasika Korde et al.
Current Medical Research and Opinion
Chronic Lymphocytic Leukemia Research
article

Zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: health-related quality of life in a subgroup of Chinese patients in the ALPINE trial

Constantine S. Tam, Tommi Salmi, L. Qiu, Rasika Korde, Ken Wu, Gisoo Barnes, Keshu Zhou, Shin Yeu Ong, Mazyar Shadman, Jennifer R. Brown
article en

Abstract

No abstract available for this paper.
Current Medical Research and OpinionVol. 42(1)
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), National University of Misiones (AR), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), University of Washington (US), Singapore General Hospital (SG), Fred Hutch Cancer Center (US), Dana-Farber Cancer Institute (US), Cancer Research Center (US), Henan Cancer Hospital (CN), Institute of Hematology & Blood Diseases Hospital (CN), Krones (Germany) (DE), Alfred Health (AU), Monash University (AU)
Openalex Percentile: Top 57%
Chronic Lymphocytic Leukemia Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: health-related quality of life in a subgroup of Chinese patients in the ALPINE trial — Constantine S. Tam, Tommi Salmi, et al. · Current Medical Research and Opinion (2026) | TGRS Research Map | TGRS